Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON |
| description | Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1852896A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1852896A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1852896A3</originalsourceid><addsrcrecordid>eNrjZPANLM3My8_JzEtVSMxLUSgE8hKrIPyU1KLMssSSzLLUYoWMxLLMvHSFxLS0zLzMkkqFtPwiBVOPEEPdksqCVIWi1OTUgpL8omIeBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GdoYWpkYWnmaExYBQAsrTWg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors</title><source>esp@cenet</source><creator>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</creator><creatorcontrib>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</creatorcontrib><description>Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061025&DB=EPODOC&CC=CN&NR=1852896A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061025&DB=EPODOC&CC=CN&NR=1852896A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</creatorcontrib><title>Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors</title><description>Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPANLM3My8_JzEtVSMxLUSgE8hKrIPyU1KLMssSSzLLUYoWMxLLMvHSFxLS0zLzMkkqFtPwiBVOPEEPdksqCVIWi1OTUgpL8omIeBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GdoYWpkYWnmaExYBQAsrTWg</recordid><startdate>20061025</startdate><enddate>20061025</enddate><creator>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</creator><scope>EVB</scope></search><sort><creationdate>20061025</creationdate><title>Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors</title><author>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1852896A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BERGAUER MARKUS,BERTANI BARBARA,BIAGETTI MATTEO,BROMIDGE STEVEN MARK,FALCHI ALESSANDRO,LESLIE COLINPHILIP,MERLO GIANCARLO,PIZZI DOMENICA ANTONIA,RINALDI MARILISA,STASI LUIGI PIERO,TIBASCO JESSICA,VON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors</title><date>2006-10-25</date><risdate>2006</risdate><abstract>Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided: wherein R1, m, X, R2, n, W, p, Y, Z, R3, R4, R5 and q have the meanings as defined in the description. Methods of preparation and uses thereof in therapy, particularly for CNS disorders such as depression or anxiety, are also disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_CN1852896A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T03%3A11%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BERGAUER%20MARKUS,BERTANI%20BARBARA,BIAGETTI%20MATTEO,BROMIDGE%20STEVEN%20MARK,FALCHI%20ALESSANDRO,LESLIE%20COLINPHILIP,MERLO%20GIANCARLO,PIZZI%20DOMENICA%20ANTONIA,RINALDI%20MARILISA,STASI%20LUIGI%20PIERO,TIBASCO%20JESSICA,VON&rft.date=2006-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1852896A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |